Abstract Oxidative damage in the brain may lead to cognitive impairments in aged humans. Further, in ageassociated neurodegenerative disease, oxidative damage may be exacerbated and associated with additional neuropathology. Epidemiological studies in humans show both positive and negative effects of the use of antioxidant supplements on healthy cognitive aging and on the risk of developing Alzheimer disease (AD). This contrasts with consistent behavioral improvements in aged rodent models. In a higher mammalian model system that naturally accumulates human-type pathology and cognitive decline (aged dogs), an antioxidant enriched diet leads to rapid learning improvements, memory improvements after prolonged treatment and cognitive maintenance. Cognitive benefits can be further enhanced by the addition of behavioral enrichment. In the brains of aged treated dogs, oxidative damage is reduced and there is some evidence of reduced AD-like neuropathology. In combination, antioxidants may be beneficial for promoting healthy brain aging and reducing the risk of neurodegenerative disease.
Introduction
Aging in most species studied to date is accompanied by the progressive accumulation of oxidative damage in many tissues [1] [2] [3] [4] [5] . The brain, in particular, is highly vulnerable to oxidative damage as it is consumes approximately 20% of the body's total oxygen, has a high content of polyunsaturated fatty acids, and lower levels of endogenous antioxidant activity relative to other tissue [6] [7] [8] . Normal metabolic processes result in the release of reactive oxygen species (ROS), which in turn can lead to oxidative damage to proteins, lipids, DNA and RNA [1] . ROS are produced primarily from mitochondria [9] , intracellular organelles that are themselves vulnerable to oxidative damage [10] .
Mitochondrial dysfunction and production of ROS may be a key contributor to the deleterious effects of aging on the brain. For example, research by Dr. Mori and others provides a significant amount of support for a role of mitochondrial dysfunction leading to oxidative damage in the brain [5, [11] [12] [13] [14] [15] [16] [17] [18] . In the senescence-accelerated mouse (SAMP8), which exhibits a shortened life-span and learning impairments, Dr. Mori has shown significant mitochondrial dysfunction is also observed in liver [5] and in heart [11] . Further, co-factors that specifically target the mitochondria to improve efficiency and reduce ROS such as acetyl-l-carnitine (ALCAR) and lipoic acid (LA) also lead to behavioral improvements and reduced oxidative damage in the brains of aged rodents [10, 18, 19] . Thus, studies in rodents support the hypothesis that oxidative damage leads to behavioral dysfunction [20] and that improving mitochondrial function and reducing oxidative damage may promote healthy brain aging [21] . In combination, based on studies in animals, oxidative damage may lead to neuronal and thus cognitive dysfunction in aging humans [22] .
In this brief review, a summary of evidence from the human literature will be presented suggesting that oxidative damage is critically involved with both normal and pathological aging. The results of a longitudinal intervention study in a canine model of aging that naturally develops cognitive decline and human-type neuropathology also provide support for the hypothesis that oxidative damage causes neuronal dysfunction. In combination, administration of antioxidants (either as supplements or within food) may be beneficial for healthy brain aging.
Oxidative Damage and Mitochondrial Dysfunction in Human Brain Aging and Alzheimer Disease
Studies in both normal and pathological human brain aging provide evidence in support of a role of oxidative damage in age-associated cognitive losses. Studies Mitochondrial function also appears compromised with age and disease in the human brain [3, 4, 14, 58] . In normal aging, mitochondrial respiratory chain activity declines [59], mitochondrial metabolism-associated enzymes such as aconitase decrease [60] and the rate of somatic mitochondrial DNA mutations increases [17, 61] . In AD, similar types of losses in respiratory chain activity [15, 62, 63] and increases in mitochondrial DNA mutations [64] are observed but are higher when compared to age-matched controls. Further, in AD, decreased cytochrome oxidase activity in the posterior cingulate cortex is correlated with hypometabolism seen by positron emission studies [65] . A new gene array study in the cingulate cortex shows that energy-metabolism related genes, and specifically a 65% reduction in expression of mitochondrial electron transport chain genes, occurs in AD [66] . Thus, mitochondrial dysfunction and the production of ROS, combined with lower endogenous antioxidant activity may lead to increasing oxidative damage to molecules critically important to neuronal function.
Ab, Oxidative Damage and Mitochondrial Dysfunction
Why is oxidative damage more extensive in the AD brain relative to nondemented aged brains? There is evidence of a link between Ab and oxidative damage that is based upon work with mouse models of AD and studies of AD brains [67, 68] . It is unclear yet whether oxidative damage may lead to Ab deposition or whether Ab leads to oxidative damage. In studies of transgenic mice that overexpresses mutant human beta-amyloid precursor protein (Tg2576), lipid peroxidation precedes Ab deposition in plaques [69] . Further, APP is increasingly oxidized with age and oxidative modification may in turn favor amyloidogenic cleavage to produce more Ab [70] . Beta-secretase protein levels are increased by the lipid peroxidation product, hydroxynonenal, which can lead to enhanced production of Ab from full length APP [71] . In turn, there is good evidence that Ab itself can cause oxidative damage [72] [73] [74] . There is also growing evidence of Ab causing mitochondrial dysfunction [67] . Ab can impair mitochondrial function through several mechanisms [75, 76] including direct interaction with Ab-binding alcohol dehydrogenase (ABAD) located within mitochondria [77] . Another key enzyme involved with the cleavage of APP to Ab, the gamma-secretase complex, also appears to be associated with mitochondria [78] . Thus, in the diseased brain, there may be a feedforward loop involving oxidative damage and Ab. Oxidative damage and mitochondrial dysfunction may lead to the production of Ab, which in turn causes more oxidative damage and mitochondrial dysfunction [79] .
Antioxidants in Human Aging and Disease
Based on neuropathology studies, antioxidants may be predicted to be associated with healthy aging and might serve as an approach to reduce the risk of developing AD. However, in contrast to robustly positive outcomes in studies using rodent models, observational studies in humans have shown a either a positive effect of antioxidant supplementation on cognition and risk reduction for developing AD [80] [81] [82] , or no significant effects [83] [84] [85] [86] . Difficulties in interpreting human observational studies stem from inconsistencies in the amount of supplements taken, their form and source, their duration and regularity of use, and from the challenges of determining the exact dietary intake of antioxidants. For example, in one study, combinations of antioxidants were superior to single supplementation [87] and dietary intake of antioxidants has been shown to be superior to supplements in human studies on cognition and risk of developing AD [81, 88] . There have been few systematic clinical trial studies evaluating the effects of antioxidants on cognition in aged individuals or patients with AD. Vitamin E, however, has been shown to delay institutionalization in AD patients, suggesting some beneficial effects [89] . However, vitamin E alone did not improve cognition in patients with mild cognitive impairment, which is thought to be a precursor to AD [90] .
In nondemented elderly women, vitamin E alone has little benefit on cognition [85] , however, one study showed that supplementation with a combination of vitamins E and C led to improved memory [91] .
There are several studies of the effects of mitochondrial co-factors specifically on cognition in patients with AD. In studies where ALCAR was administered to patients with moderate to severe AD, either improved cognition and/or slower deterioration has been observed [92] [93] [94] [95] . In earlyonset AD patients (less than 65 years of age), only small cognitive improvements were noted [96] but in other studies of younger patients with AD (less than 61 years) there was evidence for slowed disease progression [97, 98] . When the results of all these studies are combined in a meta-analysis, there were clear benefits of ALCAR administration in patients with AD, particularly with respect to slowing cognitive decline [99] . Further, combining ALCAR with acetylcholinesterase therapy in AD may provide additional benefits [100] .
Similar evidence of maintenance of function was observed in a study of 9 patients with AD or related dementias receiving 600 mg/day of LA for an average of 337 days [101] . In a follow up study of 48 patients for a longer 48 month treatment period, maintenance of function similar to the smaller study was observed [102] . Interestingly, a recent study of transgenic mice (tg2576) also showed improved learning and memory in LA treated animals with little effect on Ab pathology [103] . Thus, LA treatment may also be of benefit for AD through neurobiological mechanisms independent of Ab reduction.
There have been no human clinical trials that have combined different cellular antioxidants with mitochondrial co-factors. Thus, we tested the hypothesis that a combination antioxidant diet approach, which included cellular antioxidants, fruits and vegetables and mitochondrial co-factors, can lead to improved cognition and reduced neuropathology in brain aging. To explore these hypotheses we have been working with a canine model of aging. Work from our and other laboratories suggest that this natural model of aging provides unique advantages for the study of oxidative damage and development of AD pathology that complements currently used model systems such as transgenic mice and nonhuman primates. Unique features of the canine model include long life spans, allowing for longitudinal studies and the natural deposition of human-type Ab that does not require overexpression of mutant human genes.
The Canine Model of Human Aging
Over the past 15 years we have been working with a dog model of human brain aging. For our studies we use primarily beagles, which have a median life span of 13.5 years (equivalent for males and females). For these studies we consider animals 5 years and younger to be young, 6-10 years to be middle aged and over 10 years to be old. Additional categorization can be used depending on the criteria-for example, the age at which cognition decline or when brain pathology begins to accumulate. However, beagles over the age of 15 years may also be considered to be successful agers. The maximal lifespan of beagles is approximately 18 years.
The brains of aged dogs progressively accumulate oxidative damage to lipids, proteins, DNA and RNA [104] [105] [106] [107] [108] [109] [110] . In addition, dogs naturally develop beta-amyloid pathology [111] [112] [113] [114] [115] , which is a toxic protein implicated in Alzheimer disease [116] . Neuron loss also occurs in the hilus of the dentate gyrus [117, 118] in aged dogs along with a reduced ability to generate new neurons [119] . Less neurogenesis is correlated with poorer cognitive performance [119] . By magnetic resonance imaging, cortical atrophy and ventricular widening can be observed with age [120, 121] and is linked to both Ab and cognition [122] .
In parallel to these neuropathological events in the aged canine brain, there is a progressive loss of a subset of cognitive functions [123] [124] [125] [126] [127] [128] [129] . Further, not all aged individuals are equally affected; some aged dogs can learn and remember information as well as younger dogs. Other aged dogs can show severe cognitive impairments [124, 130] . Some types of learning and memory are more vulnerable to aging than others. For example, simple visual discrimination learning and procedural learning remains relatively intact with age in dogs [124] . In contrast, visuospatial function [129] and complex learning ability [131] are compromised with age. In a sensitive measure of spatial learning and memory, subtle age impairments can be detected as young as 6 years of age [129] .
In canines, although Ab is primarily deposited as diffuse plaques in the canine brain, there is an association between the extent of Ab and cognitive decline [132] [133] [134] [135] [136] . Oxidative damage may also be associated with behavioral decline. Rofina and collaborators found that increased oxidative end products in aged canine brain [106, 108, 134] correlates with severity of behavior changes due to cognitive dysfunction. For example a significant correlation was found between behavior changes and several measures of oxidative damage [106] . Does oxidative damage lead to Ab accumulation and, either in combination with Ab or independently of Ab, cause cognitive decline? We tested this hypothesis in a longitudinal study of aging in old beagles that we provided with a diet rich in a broad spectrum of antioxidants. In addition, we tested the hypothesis that combining an antioxidant diet with behavioral enrichment, to stimulate neurogenesis and neuronal growth factor release, would provide added benefits.
A Longitudinal Study of Antioxidants in Aged Dogs
We completed a longitudinal investigation of the effects of dietary antioxidant intervention on cognitive function of aged beagle dogs. The experimental subjects were a group of 48 aged beagles (10 to 13 years of age) and 17 young dogs (3 to 5 years old). Each animal was assigned into one of two food groups using a counter balanced design based on extensive baseline cognitive testing. No differences existed between cognitive ability of groups prior to dietary intervention [137] . The two foods were formulated to meet the nutrient profile for the American Association of Feed Control Officials recommendations for adult dogs (AAFCO 1999). Control and test diets were identical in composition, other than inclusion of a broad-based antioxidant and mitochondrial cofactor supplementation to the test diet. The control and enriched foods had the following differences in formulation on an as fed basis respectively: dlalpha-tocopherol acetate, (120 ppm vs. 1050 ppm), l-carnitine (\20 ppm vs. 260 ppm), dl-alpha-lipoic acid (\20 ppm vs. 128 ppm), ascorbic acid as Stay-C (\30 ppm vs. 80 ppm), and 1% inclusions of each of the following (1 to 1 exchange for corn): spinach flakes, tomato pomace, grape pomace, carrot granules and citrus pulp. An additional treatment was also included in the study, behavioral enrichment. The behavioral enrichment protocol consisted of housing animals in pairs (social enrichment), providing two 20 minute outdoor walks per week (physical exercise) and continuous cognitive testing (cognitive enrichment). The cognitive enrichment consisted of a landmark discrimination task [138] , an oddity discrimination task [131] , and a size discrimination learning and reversal task [133, 137] . Each of these tests measured distinct cognitive domains to minimize practice effects and served as a behavioral enrichment test battery (i.e. control animals did not receive this training). On an annual basis, a second battery of tests was used and all animals were given cognitive testing on measures of discrimination learning, reversal and spatial memory, which were different tasks than those used for the behavioral enrichment treatment. To minimize practice effects we used different stimulus objects for each successive discrimination and reversal problems and in addition, we selected objects that were more difficult for animals to distinguish. This prevented possible floor effects. For the spatial memory task, identical testing procedures were used each year and we predicted that all animals may improve with repeated exposure but that treated animals would benefit more.
After one month of treatment, we tested animals for spatial attention ability using a landmark discrimination task [123] . We observed rapid improvements in function on this measure of learning [138] . Approximately six months after starting the dietary intervention, the dogs were tested on a series of oddity discrimination learning tasks [131] . We observed both age and diet effects with old animals performing significantly worse than young dogs on all phases of the test. With respect to diet, old dogs fed the test food made significantly fewer errors on the more difficult tasks than old controls. Additional improvements in cognition in response to the antioxidant-enriched diet were observed on repeated measures of visual discrimination and reversal learning [137] . Spatial memory was also improved in aged dogs provided with the antioxidant enriched diet after long term treatment ([2.0 years) [139] . Interestingly, young dogs fed the antioxidant diet showed no cognitive improvements on the oddity task as well as other learning problems [137, 140] suggesting the antioxidant diet selectively corrected an oxidative defect present in the aged brain. In all of the cognitive outcome measures we also observed that the antioxidant diet effects were further enhanced in animals that also received behavioral enrichment [137] .
Our next experiments were intended to identify the neurobiological mechanisms underlying improved cognition in response to the antioxidant diet. In the brain, we observed decreased protein oxidation and increased endogenous antioxidant enzyme activity, but interestingly, no changes in the extent of lipid peroxidation [109] . These effects were more robust in animals receiving both the antioxidant diet and behavioral enrichment. The extent of diffuse Ab in the brains of treated animals was also reduced [141] . However, in analyzing which brain regions were affected by antioxidant treatment we found that the prefrontal cortex remained unaffected where as more posterior and ventral cortical regions (parietal cortex and entorhinal cortex) showed less Ab. Based upon previous work [112, 113] we have learned that Ab deposition occurs at different ages in distinct cortical regions in the canine brain. The prefrontal cortex shows Ab accumulation between 8 and 9 years of age whereas parietal and entorhinal cortex accumulates Ab at later ages ([10 years). Thus, given the age at which the treatment was started in the study animals, the antioxidant treatment was not able to reduce pre-existing Ab (prefrontal cortex) but prevented further Ab accumulation in the parietal and entorhinal cortex. Antioxidant benefits on the production of Ab and deposition into diffuse plaques in the canine study is consistent with a previous report of increased alpha-secretase activity in transgenic mice overexpressing mutant human beta-amyloid precursor protein and thus lowering the production of Ab in response to treatment with the antioxidant, green tea epigallocatechin-3-gallate [142] .
The mechanisms by which individual components in the diet may contribute to improved neuron function may be complex and involve multiple molecular cascades [109] . For example, primary cortical neurons pretreated with both acetyl-l-carnitine and lipoic acid prior to exposure to oxidative stress, show increased endogenous antioxidant levels [143] , which was similar to observations in treated dogs [109] . Importantly, the PI3K, PKG and ERK1/2 cell survival pathways are activated in response to acetyl-lcarnine and lipoic acid treatment [143] . Acetyl-l-carnitine alone can up-regulate heat shock proteins and protect oxidative damage in cortical neurons exposed to Ab [144] . However, the antioxidant enriched diet may have many other beneficial effects including possible anti-inflammatory properties or other direct effects on brain function that have yet to be identified.
In contrast, we have found that behavioral enrichment does not modify Ab levels but may improve or enhance the effects of the antioxidant diet by maintaining neuron number in the hippocampus, a region critically involved with learning and memory [117] . The results of these studies strongly suggest that antioxidants and behavioral enrichment improve brain function through independent molecular pathways. Thus, the use of antioxidant supplements in addition to other lifestyle modifications (increased social activity and cognitive engagement) may work additively.
Summary
In humans, oxidative damage has been observed with age in the brain and epidemiology studies also suggest that antioxidant use is beneficial for cognitive function. Further, in the age-associated neurodegenerative disorder, Alzheimer disease (AD), more extensive oxidative damage has been reported relative to normal aging and this may be due to the accumulation of additional Ab neuropathology. Targeting mitochondrial function, specifically, may provide benefits to patients with AD by slowing disease progression. Overall, recent reviews of the human epidemiological literature have emphasized that antioxidants may be one of the most promising treatments for preventing AD [145] . Thus, continuing on the theme of recent work of Dr. Akitane Mori's exploring the link between aging, oxidative damage and neurodegeneration, researchers have been making significant strides to find ways in which to promote successful brain aging. Given recent studies by Dr. Mori describing several natural compounds that may provide brain aging benefits [146] , this is an area that will continue to evolve over time. induces cytochrome C release from isolated mitochondria. NeuroReport 13:1989 NeuroReport 13: -1993 
